(Q37107512)

18 August 2017

Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, and biological activities (English)

1 reference

Clementina Maria Galluzzo

18 August 2017

0 references

Lucia Nencioni

16

0 references

Clementina Maria Galluzzo

15

0 references

Roberta Costi

Roberta Costi

2

0 references

Luciana Marinelli

Luciana Marinelli

9

0 references

Mauro Andreotti

Mauro Andreotti

13

0 references

Antonio Lavecchia

Antonio Lavecchia

8

0 references

Roberto Di Santo

Roberto Di Santo

1

0 references

Anna Teresa Palamara

Anna Teresa Palamara

17

0 references

Ettore Novellino

Ettore Novellino

11

0 references

Yves Pommier

18

Yves Pommier

1 reference

18 August 2017

Christophe H Marchand

19

Christophe Marchand

1 reference

18 August 2017

10

Carmen Di Giovanni

1 reference

18 August 2017

3

Alessandra Roux

1 reference

18 August 2017

12

Lucia Palmisano

1 reference

18 August 2017

14

Roberta Amici

1 reference

18 August 2017

4

Gaetano Miele

1 reference

Giuliana Cuzzucoli Crucitti

18 August 2017

5

Giuliana Cuzzucoli Crucitti

1 reference

18 August 2017

6

Alberto Iacovo

1 reference

18 August 2017

7

Federica Rosi

1 reference

18 August 2017

language of work or name

English

0 references

publication date

23 July 2008

1 reference

Journal of Medicinal Chemistry

18 August 2017

1 reference

18 August 2017

51

1 reference

18 August 2017

15

1 reference

18 August 2017

4744-4750

1 reference

Raltegravir (MK-0518): an integrase inhibitor for the treatment of HIV-1.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

HIV-1 integrase inhibitors: 2005-2006 update

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

Integrase inhibitors to treat HIV/AIDS.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

Inhibitors of human immunodeficiency virus integrase

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

Novel HIV-1 integrase inhibitors derived from quinolone antibiotics

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

Therapies. Confronting the limits of success.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646871

Probing HIV-1 Integrase Inhibitor Binding Sites with Position-Specific Integrase-DNA Cross-Linking Assays

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18646746

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1021/JM8001422

1 reference

18 August 2017

1 reference

18 August 2017

1 reference